3 results
Approved WMORecruiting
To determine the uptake of 99mTc-Fucoidan in a fresh thrombus of patients with acute deep vein thrombosis (DVT).
Approved WMOCompleted
To evaluate the tolerability (adverse effects) of 99mTc-Fucoidan in 10 healthy volunteers (phase I).
Approved WMOPending
The primary objective of the clinical performance study is to demonstrate the clinical performance of VENTANA PD-L1 (SP263) CDx Assay in terms of its ability to identify NSCLC patients who may benefit from treatment with volrustomig plus…